Minneapolis St. Paul Mental Health Blog

Mental Health | Cannabis is not a recommended treatment option for patients with attention-deficit/hyperactivity disorder (ADHD) due to a lack of evidence, according to a scoping review. 

Researchers from the Federal University of Rio Grande do Sul, Porto Alegre, Brazil, and McMaster University, Ontario, Canada, published their findings in the Journal of Psychiatric Research.

Researchers pulled studies published through June 27, 2022, on the effect of cannabis on ADHD symptomatology and neuropsychiatric outcomes. Sourced from MEDLINE, EMBASE, EMCARE, PsycINFO, Web of Science, Cochrane Library, and Clinicaltrials.gov, the studies included experimental and observational data. Researchers examined the study population, methods, and key findings for each study.

A total of 39 studies were included, of which 1 had a randomized and placebo-controlled design. This study showed that cannabis had no effect on ADHD. Most other literature included cross-sectional studies that examined ADHD severity and its connection to cannabis use.

Patients with co-morbid bipolar disorder and attention-deficit hyperactivity disorder (ADHD) were found to have higher odds of other co-morbid disorders...

...according to a new study published in the Australian & New Zealand Journal of Psychiatry.

Mental Health Matters | Cannabis not recommended for treatment of ADHD

Cannabis is not a recommended treatment option for patients with attention-deficit/hyperactivity disorder (ADHD) due to a lack of evidence, according to a scoping review.

Mental Health | A pediatric attention-deficient/hyperactivity disorder (ADHD) diagnosis was associated with negative impacts on some quality of life (QOL) measures such as risk of self-harm, self-efficacy, and sense of school membership, a study published in JAMA Network Openfound.

Mental Health | Saffron may enhance methylphenidate efficacy in adults with attention-deficit/hyperactivity disorder (ADHD), according to study findings published in Advances in Integrative Medicine.

Central Stimulants May Reduce Suicide Risk in Adults With Bipolar Disorder and ADHD

Treatment with a central stimulant may reduce the risk of suicide attempt and nonsuicidal self-injury in adults with a dual diagnosis of bipolar disorder and attention-deficit/hyperactivity disorder (ADHD), ...

...according to a study published online in Therapeutic Advances in Psychopharmacology.

Adolescents with ADHD were significantly more likely to have auto crashes than adolescents without ADHD,...

Mental Health Matters | increase in impulsivity in BP patients...

Investigators observed that impulsivity increased in patients with bipolar disorder who also experienced a traumatic childhood experience.

Impulsivity is significantly associated with attention-deficit/hyperactivity disorder (ADHD) and borderline personality disorder (BPD) and is indicated in bipolar disorder (BD) with the presence of traumatic childhood experiences.

Mental Health | Impulsivity in ADHD, Bipolar Disorder, or Borderline Personality Disorder

ADHD is defined by early onset (before age 12) of persistent (six months or longer) symptoms of inattention and/or hyperactivity and impulsivity that are not consistent with development, causing impairment of normal functioning in at least two settings (home, school). It is the most common psychiatric disorder in children, mostly in school-age boys.